Of chloroquine and COVID-19 - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Antiviral Research Year : 2020

Of chloroquine and COVID-19


Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research.
Fichier principal
Vignette du fichier
S0166354220301145.pdf (92.45 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

inserm-02519612 , version 1 (22-08-2022)


Attribution - NonCommercial



Franck Touret, Xavier de Lamballerie. Of chloroquine and COVID-19. Antiviral Research, 2020, 177, pp.104762. ⟨10.1016/j.antiviral.2020.104762⟩. ⟨inserm-02519612⟩
671 View
27 Download



Gmail Facebook X LinkedIn More